GlassScriptPhysician profile
Ramya Tadipatri
NPI 1386185734
$1,289.77
in general payments reported to CMS, 2019-2025
6 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.15 · 2023: $148 · 2024: $311 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627 · Consulting Fee: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.40 |
| Consulting Fee | $615.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Menarini Silicon Biosystems, INC. | $962.99 | 2024-2025 | |
| Monteris Medical Corporation | $224.15 | 2023-2024 | Neuroblate |
| Caris Mpi, INC. | $29.58 | 2025 | Mi Cancer Seek |
| Genzyme Corporation | $26.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $25.90 | 2023 | |
| Novocure INC. | $20.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramya Tadipatri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.